Pinder SE - Search Results

1

Proteomics of REPLICANT perfusate detects changes in the metastatic lymph node microenvironment.

Stevenson J, Barrow-McGee R, Yu L, Paul A, Mansfield D, Owen J, Woodman N, Natrajan R, Haider S, Gillett C, Tutt A, Pinder SE, Choudary J, Naidoo K. Stevenson J, et al. Among authors: pinder se. NPJ Breast Cancer. 2021 Mar 5;7(1):24. doi: 10.1038/s41523-021-00227-7. NPJ Breast Cancer. 2021. PMID: 33674617 Free PMC article.

2

Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers.

Julien S, Ivetic A, Grigoriadis A, QiZe D, Burford B, Sproviero D, Picco G, Gillett C, Papp SL, Schaffer L, Tutt A, Taylor-Papadimitriou J, Pinder SE, Burchell JM. Julien S, et al. Among authors: pinder se. Cancer Res. 2011 Dec 15;71(24):7683-93. doi: 10.1158/0008-5472.CAN-11-1139. Epub 2011 Oct 24. Cancer Res. 2011. PMID: 22025563 Free PMC article.

3

Oncological outcomes in rats given nephrocarcinogenic exposure to dietary ochratoxin a, followed by the tumour promoter sodium barbital for life: a pilot study.

Mantle PG, Dobrota M, Gillett CE, Odell EW, Pinder SE. Mantle PG, et al. Among authors: pinder se. Toxins (Basel). 2010 Apr;2(4):552-71. doi: 10.3390/toxins2040552. Epub 2010 Mar 31. Toxins (Basel). 2010. PMID: 22069599 Free PMC article.

4

The manufacture and assessment of tissue microarrays: suggestions and criteria for analysis, with breast cancer as an example.

Pinder SE, Brown JP, Gillett C, Purdie CA, Speirs V, Thompson AM, Shaaban AM; Translational Subgroup of the NCRI Breast Clinical Studies Group. Pinder SE, et al. J Clin Pathol. 2013 Mar;66(3):169-77. doi: 10.1136/jclinpath-2012-201091. Epub 2012 Oct 19. J Clin Pathol. 2013. PMID: 23087330 Review.

5

Comparative immunohistochemical analysis of ochratoxin A tumourigenesis in rats and urinary tract carcinoma in humans; mechanistic significance of p-S6 ribosomal protein expression.

Gazinska P, Herman D, Gillett C, Pinder S, Mantle P. Gazinska P, et al. Toxins (Basel). 2012 Sep;4(9):643-62. doi: 10.3390/toxins4090643. Epub 2012 Sep 11. Toxins (Basel). 2012. PMID: 23105973 Free PMC article.

6

Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles.

Gazinska P, Grigoriadis A, Brown JP, Millis RR, Mera A, Gillett CE, Holmberg LH, Tutt AN, Pinder SE. Gazinska P, et al. Among authors: pinder se. Mod Pathol. 2013 Jul;26(7):955-66. doi: 10.1038/modpathol.2012.244. Epub 2013 Feb 8. Mod Pathol. 2013. PMID: 23392436 Free article.

7

Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control.

de Rinaldis E, Gazinska P, Mera A, Modrusan Z, Fedorowicz GM, Burford B, Gillett C, Marra P, Grigoriadis A, Dornan D, Holmberg L, Pinder S, Tutt A. de Rinaldis E, et al. BMC Genomics. 2013 Sep 23;14:643. doi: 10.1186/1471-2164-14-643. BMC Genomics. 2013. PMID: 24059244 Free PMC article.

8

Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer.

Irshad S, Gillett C, Pinder SE, A'hern RP, Dowsett M, Ellis IO, Bartlett JM, Bliss JM, Hanby A, Johnston S, Barrett-Lee P, Ellis P, Tutt A. Irshad S, et al. Among authors: pinder se. Breast Cancer Res Treat. 2014 Apr;144(2):331-41. doi: 10.1007/s10549-014-2855-4. Epub 2014 Feb 12. Breast Cancer Res Treat. 2014. PMID: 24519386 Clinical Trial.

9

Age at diagnosis and distant metastasis in breast cancer--a surprising inverse relationship.

Purushotham A, Shamil E, Cariati M, Agbaje O, Muhidin A, Gillett C, Mera A, Sivanadiyan K, Harries M, Sullivan R, Pinder SE, Garmo H, Holmberg L. Purushotham A, et al. Among authors: pinder se. Eur J Cancer. 2014 Jul;50(10):1697-1705. doi: 10.1016/j.ejca.2014.04.002. Epub 2014 Apr 23. Eur J Cancer. 2014. PMID: 24768572

10

The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility.

Kiuchi T, Ortiz-Zapater E, Monypenny J, Matthews DR, Nguyen LK, Barbeau J, Coban O, Lawler K, Burford B, Rolfe DJ, de Rinaldis E, Dafou D, Simpson MA, Woodman N, Pinder S, Gillett CE, Devauges V, Poland SP, Fruhwirth G, Marra P, Boersma YL, Plückthun A, Gullick WJ, Yarden Y, Santis G, Winn M, Kholodenko BN, Martin-Fernandez ML, Parker P, Tutt A, Ameer-Beg SM, Ng T. Kiuchi T, et al. Sci Signal. 2014 Aug 19;7(339):ra78. doi: 10.1126/scisignal.2005157. Sci Signal. 2014. PMID: 25140053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

367 results

Search Page